Company search
Fantasy fund manager: miners and metals off to flying start
Despite the ferocious sell-off in precious metals, mining stocks are still leading the way.
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Research
Please note that this research may have been paid for by the investment company. Any opinions and ratings are not endorsed by the AIC.
Kepler Trust Intelligence
06 November 2025
IBT delivered positive performance in a down year for the index, and has soared since.
Related articles
Fantasy fund manager competition 2026
Six financial journalists select their favoured trusts for this year and beyond.
Fantasy fund manager: it’s a photo finish for the top spot
As the 2025 competition draws to a close, the top two contestants have made almost 30% in just 12 months.
Related videos
Monthly roundup: UKW changes dividend, our portfolios head-to-head and Saba snookered?
Jo, Ryan and David discuss the latest news and results in the investment trust world.
Monthly roundup: can UKW maintain its dividend, how IBT is riding the biotech recovery and why are investors buying Temple Bar?
Jo, Ryan and David discuss the latest news and results in the investment trust world.
Trust Issues: Investing in the biotech sector with IBT’s Ailsa Craig
We speak to Ailsa Craig, manager of IBT, about the most compelling opportunities in the biotech sector.
Monthly roundup: Why is SMT popular, can biotech M&A continue and who thinks it’s an AI bubble?
Jo, Ryan and David discuss the latest news and results in the investment trust world.
Related industry news
How healthy is your portfolio?
Over six months have passed since Cherry Reynard wrote about the biotech and healthcare sector for us in this article – The biotech bust: a case study...
International Biotechnology corrects valuation overstatement after dividend error
International Biotechnology Trust (IBT), the top performer in its sector over 10 years, has had to correct net asset value (NAV) statements published ...
Morning briefing: Biotech Growth rallies 37%; Grainger happy as REIT; Supermarket Income buys 10 Asda stores; LMP, UEM
Biotech Growth (BIOG) has hailed its recovery from its sector’s bear market of the past three years, posting a 36.9% total investment return for the s...
Trust Spot: Uranium fund takes breather as bids, wind-downs and buybacks keep investors on their toes
A look at October’s top risers and fallers reveals another busy month for investment companies. Best performing investment companies October’s biggest...
Investment company news brought to you by Citywire Financial Publishers Limited
and QuotedData by Marten & Co.
Data provided by Morningstar.
Company documents provided by FE fundinfo.
